Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma

被引：2

作者：

Hashmi, Hamza ^{[1
]}

Hamadani, Mehdi ^{[2
]}

Awan, Farrukh T. ^{[3
,4
]}

机构：

[1] Univ Louisville, Sch Med, Div Hematol & Oncol, James Graham Brown Canc Ctr, Louisville, KY 40292 USA

[2] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA

[3] Ohio State Univ, James Canc Hosp, Div Hematol, Columbus, OH 43210 USA

[4] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2018年 / 19卷 / 15期

关键词：

Treatment options; B-cell malignancies; non-Hodgkin lymphoma; relapsed disease; CHRONIC LYMPHOCYTIC-LEUKEMIA; BENDAMUSTINE PLUS RITUXIMAB; MANTLE-CELL; FOLLICULAR LYMPHOMA; OPEN-LABEL; MULTICENTER; INHIBITION; PI3K-DELTA; IBRUTINIB; OUTCOMES;

D O I：

10.1080/14656566.2018.1518430

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1631 / 1634

页数：4

共 25 条

[1] Phase IIIb randomized study of lenalidomide plus rituximab (R2) followed by maintenance in relapsed/refractory NHL: Analysis of patients with double-refractory or early relapsed follicular lymphoma (FL). [J].

Andorsky, David Jacob ;

Yacoub, Abdulraheem ;

Melear, Jason M. ;

Coleman, Morton ;

Kolibaba, Kathryn S. ;

Brooks, Heather Dawn ;

Bitran, Jacob D. ;

Fanning, Suzanne R. ;

Lansigan, Frederick ;

Ricker, Justin L. ;

Foon, Kenneth A. ;

Liu, Dongfang ;

Llorente, Mary ;

Li, Jiahui ;

Sharman, Jeff Porter .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[2]

[Anonymous], J CLIN ONCOL S

[3] Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial [J].

Brown, Jennifer R. ;

Hamadani, Mehdi ;

Hayslip, John ;

Janssens, Ann ;

Wagner-Johnston, Nina ;

Ottmann, Oliver ;

Arnason, Jon ;

Tilly, Herve ;

Millenson, Michael ;

Offner, Fritz ;

Gabrail, Nashat Y. ;

Ganguly, Siddhartha ;

Ailawadh, Sikander ;

Kasar, Siddha ;

Kater, Arnon P. ;

Doorduijn, Jeanette K. ;

Gao, Lei ;

Lager, Joanne J. ;

Wu, Bin ;

Egile, Coumaran ;

Kersten, Marie Jose .

LANCET HAEMATOLOGY, 2018, 5 (04) :E170-E180

[4] Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study [J].

Burris, Howard A., III ;

Flinn, Ian W. ;

Patel, Manish R. ;

Fenske, Timothy S. ;

Deng, Changchun ;

Brander, Danielle M. ;

Gutierrez, Martin ;

Essell, James H. ;

Kuhn, John G. ;

Miskin, Hari P. ;

Sportelli, Peter ;

Weiss, Michael S. ;

Vakkalanka, Swaroop ;

Savona, Michael R. ;

O'Connor, Owen A. .

LANCET ONCOLOGY, 2018, 19 (04) :486-496

[5] Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis [J].

Casulo, Carla ;

Friedberg, Jonathan W. ;

Ahn, Kwang W. ;

Flowers, Christopher ;

DiGilio, Alyssa ;

Smith, Sonali M. ;

Ahmed, Sairah ;

Inwards, David ;

Aljurf, Mahmoud ;

Chen, Andy, I ;

Choe, Hannah ;

Cohen, Jonathon ;

Copelan, Edward ;

Farooq, Umar ;

Fenske, Timothy S. ;

Freytes, Cesar ;

Gaballa, Sameh ;

Ganguly, Siddhartha ;

Jethava, Yogesh ;

Kamble, Rammurti T. ;

Kenkre, Vaishalee P. ;

Lazarus, Hillard ;

Lazaryan, Aleksandr ;

Olsson, Richard F. ;

Rezvani, Andrew R. ;

Rizzieri, David ;

Seo, Sachiko ;

Shah, Gunjan L. ;

Shah, Nina ;

Solh, Melham ;

Sureda, Anna ;

William, Basem ;

Cumpston, Aaron ;

Zelenetz, Andrew D. ;

Link, Brian K. ;

Hamadani, Mehdi .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) :1163-1171

[6] Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review [J].

Colosia, Ann ;

Njue, Annete ;

Trask, Peter C. ;

Olivares, Robert ;

Khan, Shahnaz ;

Abbe, Adeline ;

Police, Rachel ;

Wang, Jianmin ;

Ruiz-Soto, Rodrigo ;

Kaye, James A. ;

Awan, Farrukh .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05) :343-355

[7] Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma [J].

Dreyling, Martin ;

Santoro, Armando ;

Mollica, Luigina ;

Leppa, Sirpa ;

Follows, George A. ;

Lenz, Georg ;

Kim, Won Seog ;

Nagler, Arnon ;

Panayiotidis, Panayiotis ;

Demeter, Judit ;

Ozcan, Muhit ;

Kosinova, Marina ;

Bouabdallah, Krimo ;

Morschhauser, Franck ;

Stevens, Don A. ;

Trevarthen, David ;

Giurescu, Marius ;

Cupit, Lisa ;

Liu, Li ;

Koechert, Karl ;

Seidel, Henrik ;

Pena, Carol ;

Yin, Shuxin ;

Hiemeyer, Florian ;

Garcia-Vargas, Jose ;

Childs, Barrett H. ;

Zinzani, Pier Luigi .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (35) :3898-+

[8]

Epperla Narendranath, 2017, Hematol Oncol Stem Cell Ther, V10, P277, DOI 10.1016/j.hemonc.2017.05.004

[9] Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study [J].

Feugier, Pierre ;

Brice, Pauline ;

Maynadie, Marc ;

Franchi-Rezgui, Patricia ;

Hacini, Maya ;

Laurent, Guy ;

Suc, Etienne ;

Fitoussi, Olivier ;

Solal-Celigny, Philippe ;

Damaj, Ghandi ;

Haioun, Corinne ;

Leconte, Pierre ;

Lazreg, Fatima ;

Boissard, Federic ;

Pau, David ;

Salles, Gilles .

LEUKEMIA & LYMPHOMA, 2018, 59 (10) :2485-2488

[10] PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma [J].

Gopal, Ajay K. ;

Kahl, Brad S. ;

de Vos, Sven ;

Wagner-Johnston, Nina D. ;

Schuster, Stephen J. ;

Jurczak, Wojciech J. ;

Flinn, Ian W. ;

Flowers, Christopher R. ;

Martin, Peter ;

Viardot, Andreas ;

Blum, Kristie A. ;

Goy, Andre H. ;

Davies, Andrew J. ;

Zinzani, Pier Luigi ;

Dreyling, Martin ;

Johnson, Dave ;

Miller, Langdon L. ;

Holes, Leanne ;

Li, Daniel ;

Dansey, Roger D. ;

Godfrey, Wayne R. ;

Salles, Gilles A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) :1008-1018

← 1 2 3 →